Mohammed Loubidi
UMR CNRS 7311, Rue De Chartres BP 6759, CEDEX 2
Orleans, 45067, France
Orleans, 45067, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Tber et al. Pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents Against Human Neuroblastoma. Pharmaceuticals 2021, 14, 750.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 06, 2026
Design, Synthesis, and Biological Evaluation of Novel Tomentosin Derivatives in NMDA-Induced Excitotoxicity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 15, 2022
Pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 16, 2021
Unusual rearrangement of imidazo[1,5-a]imidazoles and imidazo[1,2-b]pyrazoles into imidazo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines.
Journal: RSC advances
Published: June 19, 2019
First Metal-Free Synthesis of Tetracyclic Pyrido and Pyrazino Thienopyrimidinone Molecules.
Journal: Molecules (Basel, Switzerland)
Published: April 24, 2018
A Greener and Efficient Method for Nucleophilic Aromatic Substitution of Nitrogen-Containing Fused Heterocycles.
Journal: Molecules (Basel, Switzerland)
Published: February 27, 2018
Efficient synthesis and first regioselective C-6 direct arylation of imidazo[2,1-c][1,2,4]triazine scaffold and their evaluation in H2O2-induced oxidative stress.
Journal: European journal of medicinal chemistry
Published: August 28, 2017
Synthesis of new heterocyclic compounds based on pyrazolopyridine scaffold and evaluation of their neuroprotective potential in MPP+-induced neurodegeneration.
Journal: European journal of medicinal chemistry
Published: October 18, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026